ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
2.750
-0.080 (-2.83%)
At close: Jul 18, 2025, 4:00 PM
2.760
+0.010 (0.35%)
After-hours: Jul 18, 2025, 7:59 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Other
595.00K
Log In
Log In
Log In
Log In
Upgrade
Other Growth
86.42%
Log In
Log In
Log In
Log In
Upgrade
Product
14.15M
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
United States
14.21M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-
Log In
Log In
Log In
Log In
Upgrade
Europe
531.00K
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-
Log In
Log In
Log In
Log In
Upgrade